The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

2.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

3.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

4.

AI-based liquid biopsy shows promise for detecting brain cancer

5.

Only 1 in 4 Eligible Adults Receive Lung Screening


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot